support was lost and we slid down below .32 for the first time in several weeks. Instead of the typical runup to Phase III results that you would normally see with other biotechs, we're getting flat interest from the market.
EPP Preliminary results were failed to be delivered in late Q3, so just more of the same stuff from management.
DONEIT - here is the link you asked for:
http://news.iguana2.com/bspectator/ASX/UNI/466603
Feel free to ask Clinuvel management why if they are so darn confident they will not buy any shares on the open market. Jack Wood deserves a pass on this one.
I guess their money is better invested in expensive toys, real estate, or a 1 or 2% bank ROI.
They get paid 6 figures, we take on all the risk and delays.
Kind of like a vacuum salesman that won't buy his own vacuum he's peddling.
support lost
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.57 |
Change
0.000(0.00%) |
Mkt cap ! $679.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7 | $13.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.90 | 288 | 1 |
View Market Depth
| Last trade - 09.43am 22/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
Day chart unavailable